(Q44829827)

6 December 2017

title

Vincristine exacerbates asymptomatic Charcot-Marie-tooth disease with a novel EGR2 mutation (English)

1 reference

6 December 2017

4

Kimiharu Uozumi

1 reference

6 December 2017

Tomonori Nakamura

1

1 reference

6 December 2017

Akihiro Hashiguchi

2

1 reference

6 December 2017

Shinsuke Suzuki

3

1 reference

6 December 2017

Shoko Tokunaga

5

1 reference

6 December 2017

Hiroshi Takashima

6

1 reference

6 December 2017

publication date

25 January 2012

1 reference

6 December 2017

1 reference

6 December 2017

volume

13

1 reference

6 December 2017

issue

1

1 reference

6 December 2017

page(s)

77-82

1 reference

Neurotoxicity of commonly used antineoplastic agents (second of two parts).

6 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10048-012-0313-1

Vincristine neurotoxicity in the presence of hereditary neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10048-012-0313-1

Medication-induced exacerbation of neuropathy in Charcot Marie Tooth disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10048-012-0313-1

Charcot-Marie-Tooth disease type 1A with 17p11.2 duplication. Clinical and electrophysiological phenotype study and factors influencing disease severity in 119 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10048-012-0313-1

Charcot-Marie-Tooth disease and related neuropathies: mutation distribution and genotype-phenotype correlation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10048-012-0313-1

Vincristine treatment triggering the expression of asymptomatic Charcot-Marie-Tooth disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10048-012-0313-1

Vincristine treatment revealing asymptomatic hereditary motor sensory neuropathy type 1A

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10048-012-0313-1

Acute deterioration of Charcot-Marie-Tooth disease IA (CMT IA) following 2 mg of vincristine chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10048-012-0313-1

Low dose vincristine-induced severe polyneuropathy in a Hodgkin lymphoma patient: a case report (vincristine-induced severe polyneuropathy).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10048-012-0313-1

Uneventful administration of vincristine in Charcot-Marie-Tooth disease type 1X.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10048-012-0313-1

Severe neurotoxicities in a case of Charcot-Marie-Tooth disease type 2 caused by vincristine for acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10048-012-0313-1

Vincristine induced peripheral neuropathy potentiated by voriconazole in a patient with previously undiagnosed CMT1X.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10048-012-0313-1

EGR2 mutations in inherited neuropathies dominant-negatively inhibit myelin gene expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10048-012-0313-1

Perinatal lethality and defects in hindbrain development in mice homozygous for a targeted mutation of the zinc finger gene Krox20.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10048-012-0313-1

Krox-20 controls myelination in the peripheral nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10048-012-0313-1

Mutations in the early growth response 2 (EGR2) gene are associated with hereditary myelinopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10048-012-0313-1

Novel missense mutation in the early growth response 2 gene associated with Dejerine-Sottas syndrome phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10048-012-0313-1

Functional consequences of mutations in the early growth response 2 gene (EGR2) correlate with severity of human myelinopathies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10048-012-0313-1

EGR2 mutation R359W causes a spectrum of Dejerine-Sottas neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10048-012-0313-1

A novel missense mutation in the early growth response 2 gene associated with late-onset Charcot--Marie--Tooth disease type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10048-012-0313-1

Novel EGR2 mutation R359Q is associated with CMT type 1 and progressive scoliosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10048-012-0313-1

In vivo detection of Egr2 binding to target genes during peripheral nerve myelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10048-012-0313-1

Neuropathy-Associated Egr2 Mutants Disrupt Cooperative Activation of Myelin Protein Zero by Egr2 and Sox10

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10048-012-0313-1

Induction of myelin protein zero by early growth response 2 through upstream and intragenic elements

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10048-012-0313-1

Regulation of the PMP22 gene through an intronic enhancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10048-012-0313-1

Early recognition of hereditary motor and sensory neuropathy type 1 can avoid life-threatening vincristine neurotoxicity

21 January 2018

1 reference

12 December 2020

Pathomechanisms of mutant proteins in Charcot-Marie-Tooth disease

1 reference

12 December 2020

The biology and pathobiology of Schwann cells.

1 reference

12 December 2020

Acute vincristine neurotoxicity in a non-Hodgkin's lymphoma patient with Charcot-Marie-Tooth disease

1 reference

12 December 2020

Are platinum-based chemotherapeutic drugs safe for patients with Charcot-Marie-Tooth disease?

1 reference

12 December 2020

10.1007/S10048-012-0313-1

Identifiers

DOI

1 reference

6 December 2017

1 reference